PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jlrJournal of Lipid Research
 
J Lipid Res. 2010 October; 51(10): 2922–2928.
PMCID: PMC2936762

ABCB4 mediates diet-induced hypercholesterolemia in laboratory opossums[S]

Abstract

High-responding opossums are susceptible to developing hypercholesterolemia on a high-cholesterol diet, but low-responding opossums are resistant. The observation of low biliary cholesterol and low biliary phospholipids in high responders suggested that the ABCB4 gene affects response to dietary cholesterol. Two missense mutations (Arg29Gly and Ile235Leu) were found in the ABCB4 gene of high responders. High responders (ATHH strain) were bred with low responders (ATHE or ATHL strain) to produce F1 and F2 progeny in two different genetic crosses (KUSH6 and JCX) to determine the effect of ABCB4 allelic variants on plasma cholesterol concentrations after a dietary challenge. Pedigree-based genetic association analyses consistently implicated a variant in ABCB4 or a closely linked locus as a major, but not the sole, genetic contributor to variation in the plasma cholesterol response to dietary cholesterol. High responders, but not low responders, developed liver injury as indicated by elevated plasma biomarkers of liver function, probably reflecting damage to the canalicular membrane by bile salts because of impaired phospholipid secretion. Our results implicate ABCB4 as a major determinant of diet-induced hypercholesterolemia in high-responding opossums and suggest that other genes interact with ABCB4 to regulate lipemic response to dietary cholesterol.

Keywords: Phospholipid, Monodelphis domestica, bile, liver disease

The laboratory opossum (Monodelphis domestica) is an omnivorous mammal. Unlike mice, rabbits, and other small mammals typically used in research on genetic control of plasma lipids, this species has a natural diet that is similar to a natural human diet in being balanced between vegetable and animal sources and including moderate levels of cholesterol. The predominant form of hypercholesterolemia in Western human societies is caused by a response to dietary cholesterol and fat. However, identification of the genes that control response has been elusive in research involving human subjects or conventional animal models.

The discovery that some laboratory opossums develop an extreme lipemic response to dietary cholesterol whereas others have a minimal response (1) provided an opportunity to identify one or more genes that affect diet-induced hypercholesterolemia and to determine mechanisms by which those genes influence cholesterol homeostasis. Therefore, we developed a partially inbred strain (ATHH) that develops highly elevated levels (10- to 30-fold) of very low density and low density lipoprotein cholesterol (V+LDLC) when fed a high-cholesterol, high-fat (HCHF) or a high-cholesterol, low-fat (HCLF) diet (2, 3), and two other partially inbred strains (ATHE and ATHL) that only develop slightly elevated levels (<2-fold) of V+LDLC when fed the same cholesterol-enriched diets. The V+LDLC levels of high- and low-responding opossums do not differ on a basal diet.

Using these strains, we demonstrated differences between high and low responders in cholesterol absorption (4), cholesterol metabolism (5), and expression of genes that regulate cholesterol homeostasis (6, 7). Genetic analyses of plasma lipoprotein cholesterol levels from pedigreed families implicated a recessive allele at a single gene locus as largely responsible for diet-induced hypercholesterolemia in high-responding opossums (8), but neither the identity of the locus nor of any candidate gene was identified.

In studying the effects of a cholesterol absorption inhibitor on plasma cholesterol, we observed a significant difference in biliary cholesterol concentrations between high and low responders on the HCLF diet, suggesting that biliary cholesterol excretion could be impaired in high responders (9). The association of high concentrations of plasma V+LDLC with low concentrations of biliary cholesterol in high responders led us to hypothesize that impaired secretion of cholesterol into bile affects excretion of cholesterol and thereby elevates plasma V+LDLC concentrations.

In the present study, we considered genes that play a role in biliary cholesterol secretion as candidate genes that control the plasma cholesterol response to the HCHF diet, and we carried out experiments to determine if any of these genes play a major role in diet responsiveness. Genes that are known to play a role in biliary cholesterol secretion are ABCG5, ABCG8, ABCB4, and NPC1L1. The ABCG5 and ABCG8 genes encode proteins that dimerize to form a functional transporter to efflux cholesterol from the liver into bile (10, 11), whereas the NPC1L1 gene encodes the Niemann-Pick C1-like 1 protein, which functions in the reverse process to transport cholesterol from canalicular bile back into the liver (12). The protein encoded by the ABCB4 gene translocates phosphatidylcholine from the inner to the outer leaflet of the canalicular membrane of hepatocytes to form mixed micelles with bile salts in the canalicular lumen (13). Phospholipids are essential for solubilization of cholesterol in bile (1315).

The NPC1L1 gene was ruled out as a strong candidate gene due to the observation of lower levels of hepatic NPC1L1 mRNA in high responders relative to those in low responders on the HCLF diet (9). The downregulation of the NPC1L1 gene is likely to be a consequence of low levels of biliary cholesterol in high responders (hence, promoting the retention of biliary cholesterol in the gall bladder); therefore, NPC1L1 is not a logical candidate for causing low biliary cholesterol in high responders. We proceeded to evaluate ABCG5, ABCG8, and ABCB4 as logical candidate genes. Our results implicate ABCB4 as a major determinant of responsiveness to dietary cholesterol in laboratory opossums.

MATERIALS AND METHODS

Laboratory opossums

The laboratory opossums used in this investigation were produced at the Southwest Foundation for Biomedical Research and were maintained under standard conditions for this species (16). Three partially inbred strains were used. All three strains were derived from nine founders trapped near the town of Exu, Brazil, in 1978 (16). The ATHH strain had been selected for high lipemic response to the HCHF diet, whereas the ATHE and ATHL strains had been selected for low response. F1 and F2 generation animals were produced from matings of ATHH × ATHE (the KUSH6 cross) and ATHH × ATHL (the JCX cross). The inbreeding coefficients of the parentals used in crosses were 0.725–0.768 for ATHH, 0.787–0.872 for ATHE, and 0.881–0.935 for ATHL. As the three strains were derived from the same nine founders, they are closely related. Kinship coefficients of the pairs of strains are 0.69 for ATHH-ATHE, 0.24 for ATHH-ATHL, and 0.24 for ATHE-ATHL.

The research was conducted in conformity with the Public Health Service Policy on Humane Care and Use of Laboratory Animals, and the studies were approved by the Institutional Animal Care and Use Committee.

Diet protocol

The basal diet on which the opossums were maintained was a commercial pelleted fox food (Reproduction Diet, Nutritionally Complete Fox Food Pellets; Milk Specialties Products, New Holstein, WI). The fat content was 10% of dry weight (3% basal fat, 4.7% lard, and 2.3% corn oil), and the cholesterol content was 0.16% of dry weight. The challenge diet, which was fed to the opossums for four weeks, was prepared by adding lard and crystalline cholesterol to the basal diet, as well as water, mixing the ingredients in a Hobart food mixer, and passing the mix through a meat grinder to produce soft pellets which were kept frozen until use. Its fat content was 18.8% (2.7% basal fat, 14.0% lard, and 2.1% corn oil), and the cholesterol content was 0.71% of dry weight (3).

Plasma cholesterol and triglyceride assays

Blood was collected into tubes containing EDTA from animals that were fasted overnight by cardiac puncture under isoflurane anesthesia. Plasma was obtained by centrifugation, and plasma total cholesterol (TC), high density lipoprotein cholesterol (HDLC), and triglycerides (TG) were measured by enzymatic methods with the Ciba-Corning Express Plus Analyzer as described previously (3). V+LDLC concentration was calculated as the difference between TC concentration and HDLC concentration.

Hepatic function markers

Analyses of alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyl transferase (GGT), and total bilirubin in plasma samples were performed on a Beckman Unicell DxC600 Chemistry Analyzer (Beckman Coulter, Fullerton, CA).

Biliary phospholipid and biliary cholesterol assays

Bile was collected from the gall bladders of animals 4 h after they were fed. For measurement of biliary phospholipids, a small volume (25–50 µl) of bile was extracted with chloroform and methanol (2:1) by the method of Folch et al. (17). The chloroform extract was dried under air, and the residue was dissolved in a small volume of chloroform and methanol (2:1). The extract was digested with 10 N sulfuric acid at 150–160°C for 3 h. Phosphorus in the digested extract was measured by the method of Bartlett (18). Phospholipid concentration was calculated by multiplying the phosphorus amount by a factor of 25 and expressed as mg/ml of bile.

Biliary cholesterol was measured using the Cholesterol E kit (Wako Diagnostics, Richmond, VA). The manufacturer's protocol was modified to accommodate the small volume of bile samples. The assay was performed by adding 2 μl of a bile sample to 0.2 ml of reagent in a 96-well plate. Color development was read on a Multiskan Spectrum spectrophotometer (Thermo Scientific, Waltham, MA).

Sequencing of opossum ABCB4 cDNA

Total RNA was isolated from the livers of four high responders from the ATHH stock and four low responders from the ATHE stock using the TRI Reagent (Molecular Research Center, Cincinnati, OH). The ABCB4 cDNA was amplified from total RNA by RT-PCR using six sets of overlapping primers (supplementary Table I). The PCR products were sequenced using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) on an ABI Prism 3730 DNA sequencer (Applied Biosystems). Sequence data were analyzed to identify gene mutations using the MacVector software (Cary, NC).

TaqMan genotyping assay

Genomic DNA was isolated from ear pinna and liver samples by the proteinase K-phenol-chloroform extraction method. DNA was quantified using an ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). Genotyping was carried out with two TaqMan probes for allelic discrimination of the ABCB4 Ile235Leu polymorphism. Forward and reverse primers for the TaqMan assay were 5′-ctatctttccaattttccctaaatatttgggttt-3′ and 5′-tggcataggctgctaattctttgt-3′, respectively. The Vic-labeled TaqMan probe (VIC-attgttattccagttactatc) was complementary to the DNA of high responders, and the FAM-lableled TaqMan probe (FAM-ttgttattccagatactatc) was complementary to the DNA of low responders. PCR amplification was performed on the GeneAmp 9700 thermal cycler (Applied Biosystems), and fluorescence intensity was read on the 7900HT Fast Real-Time PCR System (Applied Biosystems). Fluorescence data were analyzed using the Sequence Detection System software (Applied Biosystems) to assign allele types to the samples.

Statistical analyses of two genetic crosses

For each of the KUSH6 and JCX crosses, we analyzed data on plasma concentrations of TC, HDLC, V+LDLC, and TG measured at two time points in the same group of animals; i.e., at “week 0” prior to a shift from a basal diet low in cholesterol and fat, and then following a four-week exposure to the HCHF challenge diet ("week 4"). Resulting from controlled mating relevant to the current study's aims, the more than 1,300 opossums with data also belong to a large, genetically managed, pedigreed breeding colony with tens of thousands of members in many generations. Approximately 600 KUSH6 animals with data fit into six “trimmed” pedigrees with 675 total members; the largest of these contained F1 and F2 animals with data from four different generations, and the remaining five contained data from only two generations. Five extended pedigrees with 871 total members comprised the JCX cross, with all 700-plus F1 and F2 animals from which we obtained data in two generations. Numbers of relative pairs with data in each cross, an indicator of pedigree complexity and a source of much of the information necessary to estimate genetic effect size, are provided in Table 1. Pedigree, phenotype, and genotype data management were accomplished using PEDSYS (19).

TABLE 1.
Relative pairs with data in two genetic crosses of opossums

We conducted statistical genetic analyses on the data obtained from animals resulting from both crosses to determine if a single nucleotide polymorphism (SNP) within ABCB4 or another variant with which it is in linkage disequilibrium (LD) exerts a significant mean effect on variation in the phenotypes. All statistical genetic analyses were conducted within a maximum likelihood framework using variance decomposition methods implemented within the computer software package SOLAR (20). The methods implemented in this approach are designed explicitly to be used in the analysis of data from relatives in pedigrees of arbitrary size and complexity, including pedigrees with inbred offspring. We used this approach to estimate the contribution of specific genetic variants and additional genes in the polygenic background on the residual phenotypic variance (i.e., that remaining after accounting for the effects of measured covariates and random environmental factors) in each of the four traits. Tests of significance for parameters of interest were done by means of likelihood ratio tests wherein the loge likelihood for the restricted model in which the parameter is constrained to equal 0 is compared with that of a model in which the parameter is estimated.

Provided a trait exhibited significant heritability (h2), we conducted a series of pedigree-based genetic association analyses using the measured genotype approach (21, 22) in which we treated the combination of two alleles at the ABCB4 marker locus as a fixed effect on the mean of each phenotype. We included (and tested for) both an additive genetic effect and a dominance genetic effect of the locus (or another locus in tight LD with it) in an extension of the same genetic model used to detect and estimate heritability for each of the traits.

RESULTS

Assessment of candidate genes

To decide the most likely candidate among ABCG5, ABCG8, and ABCB4, we measured cholesterol and phospholipids in bile samples from five high and five low responders fed the HCHF diet for four weeks (Table 2). Biliary cholesterol concentrations of high responders were lower (4-fold; P = 0.0002) than those of low responders, and biliary phospholipid concentrations of high responders were also lower than those of low responders (4-fold; P = 0.0001). The association of low biliary cholesterol with low biliary phospholipids in high responders implicated ABCB4 (but not ABCG5 or ABCG8) as a strong candidate gene because mutations in the ABCG5 and ABCG8 proteins do not affect phospholipid secretion (15).

TABLE 2.
Biliary lipids and plasma parameters of liver function (mean ± SD) in five high- and five low-responding opossums after four weeks on HCHF diet

ABCB4 facilitates the secretion of phospholipids into the canaliculi, where phospholipids form mixed micelles with bile salts to solubilize cholesterol and protect the canalicular membrane from damage by the detergent effects of bile salts (23, 24). As shown in Table 2, elevated levels of liver function markers AST, ALT, GGT, and bilirubin in the plasma of high responders indicate liver damage, which is consistent with a deficiency in ABCB4.

SNPs in opossum ABCB4 cDNA

A 3837 bp opossum ABCB4 cDNA (GenBank accession number GU230140) was amplified by RT-PCR and sequenced. Five SNPs were detected in the ABCB4 cDNA by comparing the sequences of four low responders from the ATHE stock and four high responders from the ATHH stock (Table 3). Two SNPs cause amino acid substitutions in the amino-terminus of ABCB4; Arg at amino acid 29 in low responders is substituted by Gly in high responders, and Ile at amino acid 235 in low responders is substituted by Leu in high responders. A TaqMan assay was developed to genotype the Ile235Leu polymorphism in opossums from the KUSH6 and JCX crosses. Allele 1 carries the missense mutations whereas allele 2 is the wild-type allele.

TABLE 3.
SNPs and amino acid substitutions in ABCB4 cDNA

Statistical genetic analyses of KUSH6 and JCX crosses

Genotype data.

We typed the ABCB4 SNP Ile235Leu in 424 KUSH6 animals and 640 JCX animals; 404 of the KUSH6 and 536 of the JCX opossums that were genotyped were from the F2 generation. Respectively, the relative frequencies of the two alleles, designated “1” and “2” in this study, were 0.48 and 0.52 (KUSH6) and 0.46 and 0.54 (JCX). The relative genotypic frequencies in animals from the F2 generation of each of these two pedigreed groups (Table 4) did not depart from expectations under Hardy-Weinberg equilibrium (KUSH6: χ22 = 2.88, 0.50 > P > 0.10 and JCX: χ22 = 0.121, 0.975 > P > 0.90).

TABLE 4.
Relative genotypic frequencies at the ABCB4 SNP in the F2 generation of two genetic crosses of opossums

Correlation and heritability.

As would be expected, the four traits were intercorrelated in both genetic crosses. While the absolute values of the phenotypic correlations (ρP) differed by cross and diet, the patterns of trait-pair correlations were similar irrespective of these factors, with the highest correlations between TC and the two major lipoproteins, V+LDLC and HDLC (ρP = 0.68–0.84); intermediate correlations between V+LDLC and HDLC (ρP = 0.11–0.41); and the lowest correlations between TG and the other traits (ρP = 0.06–0.28). Our estimates of heritability for all four traits on the two diets in both crosses were significant and of similar magnitudes, ranging from h2 = 0.33 to h2 = 0.58 in the KUSH6 cross and from h2 = 0.19 to h2 = 0.40 in the JCX cross (Table 5).

TABLE 5.
Heritability

Measured genotype analysis.

We detected no evidence for association in the analyses of data from week 0 in either cross. However, in our analyses of week 4 data, we found that variation at the typed SNP in ABCB4 exerted a significant effect on all four traits in the JCX cross and on the most highly correlated pair of traits, TC and V+LDLC, in the KUSH6 cross, even after employing the overly conservative Bonferroni correction for multiple tests. In all instances, the maximum likelihood estimate of the mean effect (i.e., the “β” in Table 6) of the “2” allele(s) at the polymorphic site or the variant in LD with it was negative; i.e., lowering the plasma concentration of the selected lipid/lipoprotein traits (Figs. 1 and and2).2). In the JCX cross, we detected both significant additive and dominance components to the genetic variance for three of the traits measured after four weeks on the challenge diet—TC, V+LDLC, and TG—and additive effects only on HDLC. The level of confidence (i.e., P value) for the associations and the magnitudes of the detected mean effects of allelic variation at (or in LD with) this SNP were substantially higher for the highly correlated TC and V+LDLC than for HDLC and TG. Genotypic variation at the ABCB4 SNP accounted for approximately 16% of the residual phenotypic variance and 65% to 82% of the genetic variance in TC and V+LDLC, respectively; and 4% to 7% of the phenotypic variance and 10% to 37% of the genetic variance in HDLC and TG, respectively. In our analyses of data from the KUSH6 cross, we detected significant additive effects (but not dominance effects) of the ABCB4 SNP that accounted for roughly 6.5% of the residual phenotypic variance and 16% of the genetic variance in both TC and V+LDLC.

Fig. 1.
Plasma lipoprotein cholesterol concentrations by ABCB4 genotypes in KUSH6 opossums before and after dietary challenge. HDLC, high density lipoprotein cholesterol; TC, total cholesterol; V+LDLC, very low density and low density lipoprotein cholesterol. ...
Fig. 2.
Plasma lipoprotein cholesterol concentrations by ABCB4 genotype in JCX opossums before and after dietary challenge. HDLC, high density lipoprotein cholesterol; TC, total cholesterol; V+LDLC, very low density and low density lipoprotein cholesterol.
TABLE 6.
Measured genotype analysis

DISCUSSION

The selection of ABCB4 as a candidate gene for investigation in the present study was prompted entirely by differences in biliary lipids between high- and low-responding opossums. The work presented here was conducted independently of a whole genome scan of lipemic response to the HCHF diet in another genetic cross (neither KUSH6 nor JCX) (Kammerer et al., unpublished observations), although the results obtained from that genome scan implicate a region of opossum chromosome 8 that harbors ABCB4.

Detection of significant and substantive genetic effects on plasma lipid and lipoprotein concentrations in the KUSH6 and JCX animals was not unexpected, given our described breeding protocols for the two crosses. Further, while we consider nonzero heritability estimates to be a logical precondition to testing hypotheses about the effects of ABCB4 or any other gene on these phenotypes, the magnitude of the total heritability estimate for a trait provides a basis for assessing both the relative genetic importance of the typed gene/variant as well as the likely importance of other genes/variants at other, nontyped (or yet to be discovered) loci.

Given that we observed significant effects of genotypic variation at the typed SNP on the lipoprotein phenotypes in both genetic crosses but only in the analyses of data from the HCHF-challenge diet, we conclude that ABCB4 is a diet-response gene. This interpretation is consistent with the outcomes of our locus-specific linkage analyses as well (detailed results not presented).

While allelic variation at or in tight LD with the SNP in ABCB4 accounts for a far greater proportion of the total additive genetic effects on the studied phenotypes in animals from the JCX cross than in those from the KUSH6 cross, it does not account for all the detected genetic effects in either group. Other genes responsible for a significant proportion of the total additive genetic effects on these phenotypes remain to be identified. Based on our estimates of the total heritability and effect size attributable to variation at the SNP, we estimate that these gene(s) could account for at least 10% and up to 40% of the additive genetic effects on lipemic response to diet.

The dominance effect, detected only in the JCX cross (and responsible for the difference in effect sizes between the two crosses), may provide a clue to the nature of the effects of this unidentified gene(s). In studies like the present one in which the effects of both the ABCB4 locus and the multiple loci making up the polygenic background (i.e., residual heritability) are considered, a significant dominance effect (which, strictly defined, refers to interactions between alleles at one locus) can also implicate epistatic interactions with genes at other loci (25). Although not conclusive evidence for a specific mechanism of gene action or for the existence of additional variants either at the ABCB4 locus or at other loci, observation of a significant dominance effect in one cross, but not both, is consistent with the following simple hypotheses: (1) In the JCX cross, the SNP (or a variant in tight LD with it) interacts with either another variant in ABCB4 or with a variant in a gene elsewhere in the genome; and (2) This variant is present in a higher frequency in animals from the JCX cross than in those from the KUSH6 cross, in which it could be absent.

Our results do not rule out the possibility that a gene closely linked to ABCB4, rather than ABCB4 itself, is responsible for controlling diet responsiveness in these opossums. However, we again note that ABCB4 was nominated as a candidate based on biliary lipids data. Moreover, the results of a whole genome scan are consistent with our nomination of ABCB4 (Kammerer et al., unpublished observations). No other gene is known to affect levels of biliary phospholipids and biliary cholesterol, so the coalescence of the results from the candidate gene strategy and the independently derived results from the genome scan makes it improbable that the results of our statistical genetic analyses are due to the effects of a closely linked gene, rather than to ABCB4.

CONCLUSION

We provided evidence suggesting that ABCB4 is a major determinant of diet-induced hypercholesterolemia in high-responding opossums. It is known that mutations in the human ABCB4 gene cause or predispose to hepatobiliary diseases whose clinical symptoms are due to the production of bile with a low phospholipid content and a high cholesterol saturation index (24, 26). Acalovschi et al. (27) examined four human ABCB4 variants and did not observe an association between high plasma lipid levels and rare ABCB4 alleles. However, the results of that study do not exclude the possibility that plasma cholesterol in humans can be influenced by other common or rare ABCB4 variants. This locus should be thoroughly investigated in several human populations in relation to interaction with dietary cholesterol that may affect plasma cholesterol levels.

Supplementary Material

Supplemental Data:

Acknowledgments

The authors thank Janice MacRossin, Susan Mahaney, Cynthia Mermeia, and Sam Galindo for technical assistance; Chéri Spencer, Jim Bridges, and Deborah Newman for data management and analytical support; and Don Taylor and his staff for management of the opossum colony.

Footnotes

Abbreviations:

ALT
alanine aminotransferase
AST
aspartate aminotransferase
GGT
γ-glutamyl transferase
HCHF
high cholesterol and high fat
HCLF
high cholesterol and low fat
HDLC
high density lipoprotein cholesterol
LD
linkage disequilibrium
SNP
single nucleotide polymorphism
TC
total cholesterol
TG
triglyceride
V+LDLC
very low density and low density lipoprotein cholesterol

This work was supported by National Institutes of Health Grant R01 DK-065058. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The opossum breeding colony and production of the partially inbred strains were supported by a grant from the Robert J. Kleberg, Jr., and Helen C. Kleberg Foundation.

[S]The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of a table.

REFERENCES

1. VandeBerg J. L., Cheng M-L. 1985. Dyslipoproteinemia in a laboratory marsupial, Monodelphis domestica. Isozyme Bull. 18: 66.
2. Rainwater D. L., VandeBerg J. L. 1992. Dramatic differences in lipoprotein composition among gray short-tailed opossums (Monodelphis domestica) fed a high cholesterol/saturated fat diet. Biochim. Biophys. Acta. 1126: 159–166. [PubMed]
3. Kushwaha R. S., VandeBerg J. F., VandeBerg J. L. 2004. Effect of dietary cholesterol with or without saturated fat on plasma lipoprotein cholesterol levels in the laboratory opossum (Monodelphis domestica) model for diet-induced hyperlipidaemia. Br. J. Nutr. 92: 63–70. [PubMed]
4. Kushwaha R. S., VandeBerg J. F., Rodriguez R., VandeBerg J. L. 2004. Cholesterol absorption and hepatic acyl-coenzyme A:cholesterol acyltransferase activity play major roles in lipemic response to dietary cholesterol and fat in laboratory opossums. Metabolism. 53: 817–822. [PubMed]
5. Kushwaha R. S., VandeBerg J. F., Jackson E. M., VandeBerg J. L. 2001. High and low responding strains of laboratory opossums differ in sterol 27-hydroxylase and acyl-coenzyme A:cholesterol acyltransferase activities on a high cholesterol diet. J. Nutr. Biochem. 12: 664–673. [PubMed]
6. Chan J., Donalson L. M., Kushwaha R. S., Ferdinandusse S., VandeBerg J. F., VandeBerg J. L. 2008. Differential expression of hepatic genes involved in cholesterol homeostasis in high- and low-responding strains of laboratory opossums. Metabolism. 57: 718–724. [PMC free article] [PubMed]
7. Chan J., Kushwaha R. S., VandeBerg J. F., Gluhak-Heinrich J., VandeBerg J. L. 2010. Differential expression of intestinal genes in opossums with high and low responses to dietary cholesterol. J. Nutrition Metabolism 2010: Article ID 415075, 8 pages. doi:10.1155/2010/415075 [PMC free article] [PubMed]
8. Rainwater D. L., Kammerer C. M., Singh A. T. K., Moore P. H., Jr, Poushesh M., Shelledy W. R., VandeBerg J. F., Robinson E. S., VandeBerg J. L. 2000. Genetic control of lipoprotein phenotypes in the laboratory opossum, Monodelphis domestica. GeneScreen. 1: 117–124.
9. Chan J., Kushwaha R. S., VandeBerg J. F., VandeBerg J. L. 2008. Effect of ezetimibe on plasma cholesterol levels, cholesterol absorption, and secretion of biliary cholesterol in laboratory opossums with high and low responses to dietary cholesterol. Metabolism. 57: 1645–1654. [PMC free article] [PubMed]
10. Yu L., Hammer R. E., Li-Hawkins J., Von Bergmann K., Lutjohann D., Cohen J. C., Hobbs H. H. 2002. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA. 99: 16237–16242. [PubMed]
11. Yu L., Li-Hawkins J., Hammer R. E., Berge K. E., Horton J. D., Cohen J. C., Hobbs H. H. 2002. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 110: 671–680. [PMC free article] [PubMed]
12. Temel R. E., Tang W., Ma Y., Rudel L. L., Willingham M. C., Ioannou Y. A., Davies J. P., Nilsson L. M., Yu L. 2007. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J. Clin. Invest. 117: 1968–1978. [PubMed]
13. Smit J. J. M., Schinkel A. H., Oude Elferink R. P. J., Groen A. K., Wagenaar E., van Deemter L., Mol C. A. A. M., Ottenhoff R., van der Lugt N. M. T., van Roon M. A., et al. 1993. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75: 451–462. [PubMed]
14. Oude Elferink R. P. J., Ottenhoff R., van Wijland M., Smit J. J. M., Schinkel A. H., Groen A. K. 1995. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J. Clin. Invest. 95: 31–38. [PMC free article] [PubMed]
15. Langheim S., Yu L., von Bergmann K., Lütjohann D., Xu F., Hobbs H. H., Cohen J. C. 2005. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile. J. Lipid Res. 46: 1732–1738. [PubMed]
16. VandeBerg J. L., Williams-Blangero S. 2010. The laboratory opossum. The UFAW Handbook on the Care and Management of Laboratory and Other Research Animals. 8th edition Hubrecht R., Kirkwood J., editors. , Wiley-Blackwell, Oxford: 246–262.
17. Folch J., Lees M., Sloane Stanley G. H. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497–509. [PubMed]
18. Bartlett G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234: 466–468. [PubMed]
19. Dyke B. 1996. PEDSYS: A Pedigree Data Management System User's Manual. Technical Report No. 2. Population Genetics Laboratory, Southwest Foundation for Biomedical Research, San Antonio, TX.
20. Almasy L., Blangero J. 1998. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62: 1198–1211. [PubMed]
21. Boerwinkle E., Chakraborty R., Sing C. F. 1986. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann. Hum. Genet. 50: 181–194. [PubMed]
22. Boerwinkle E., Sing C. F. 1987. The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein and triglyceride levels. Ann. Hum. Genet. 51: 211–226. [PubMed]
23. van Nieuwerk C. M., Groen A. K., Ottenhoff R., van Wijland M., van den Bergh Weerman M. A., Tytgat G. N., Offerhaus J. J., Oude Elferink R. P. 1997. The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. J. Hepatol. 26: 138–145. [PubMed]
24. Oude Elferink R. P. J., Paulusma C. C. 2007. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch. 453: 601–610. [PubMed]
25. Falconer D. S. 1981. Introduction to Quantitative Genetics. 3rd ed John Wiley & Sons, New York.
26. Gonzales E., Davit-Spraul A., Baussan C., Buffet C., Maurice M., Jacquemin E. 2009. Liver diseases related to MDR3 (ABCB4) gene deficiency. Front. Biosci. 14: 4242–4256. [PubMed]
27. Acalovschi M., Tirziu S., Chiorean E., Krawczyk M., Grünhage F., Lammert F. 2009. Common variants of ABCB4 and ABCB11 and plasma lipid levels: a study in sib pairs with gallstones, and controls. Lipids. 44: 521–526. [PubMed]

Articles from Journal of Lipid Research are provided here courtesy of American Society for Biochemistry and Molecular Biology